Chemotherapy: Optimizing irinotecan regimens for colorectal cancer

MeSH terms

• Alleles
• Antibodies, Monoclonal / therapeutic use
• Antibodies, Monoclonal, Humanized
• Antineoplastic Agents / therapeutic use
• Antineoplastic Agents, Phytogenic / therapeutic use*
• Antineoplastic Combined Chemotherapy Protocols
• Camptothecin / analogs & derivatives*
• Camptothecin / therapeutic use
• Cetuximab
• Clinical Trials, Phase II as Topic
• Colorectal Neoplasms / drug therapy*
• Colorectal Neoplasms / mortality
• Colorectal Neoplasms / pathology
• Colorectal Neoplasms / secondary*
• Diarrhea / chemically induced
• Disease Progression
• Disease-Free Survival
• Dose-Response Relationship, Drug
• Drug Administration Schedule
• Drug Therapy / methods*
• Drug Therapy, Combination
• Fluorouracil / therapeutic use
• Follow-Up Studies
• Gene Frequency
• Glucuronosyltransferase / genetics
• Humans
• Infusions, Intravenous
• Irinotecan
• Leucovorin
• Neutropenia / chemically induced
• Organoplatinum Compounds / therapeutic use
• Oxaliplatin
• Polymorphism, Genetic
• Quality of Life
• Survival Analysis
• Time Factors
• Treatment Outcome